276 related articles for article (PubMed ID: 8572832)
1. ACE inhibitors as a shield against diabetic nephropathy.
Materson BJ
Arch Intern Med; 1996 Feb; 156(3):239-40. PubMed ID: 8572832
[No Abstract] [Full Text] [Related]
2. ACE inhibitors and renoprotection.
Peterson K
J Fam Pract; 1996 May; 42(5):453. PubMed ID: 8642355
[No Abstract] [Full Text] [Related]
3. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
Luño J; Valderrábano F
An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
[No Abstract] [Full Text] [Related]
4. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
5. Nephropathy in patients with type 2 diabetes mellitus.
Ritz E; Orth SR
N Engl J Med; 1999 Oct; 341(15):1127-33. PubMed ID: 10511612
[No Abstract] [Full Text] [Related]
6. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment.
Parving HH
Diabetologia; 1998 Jul; 41(7):745-59. PubMed ID: 9686914
[No Abstract] [Full Text] [Related]
7. Diabetic nephropathy and renal protective agents.
Marchiando R; Elston MP
S D J Med; 1999 Oct; 52(10):385-6. PubMed ID: 10546516
[No Abstract] [Full Text] [Related]
8. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
Ravid M; Lang R; Rachmani R; Lishner M
Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
[TBL] [Abstract][Full Text] [Related]
9. Practical problems in the management of hypertension in the diabetic patient.
O'Hare JP
J Diabetes Complications; 1996; 10(3):146-8. PubMed ID: 8807462
[No Abstract] [Full Text] [Related]
10. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Erman A; Boner G; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
[TBL] [Abstract][Full Text] [Related]
11. Preserving the diabetic kidney.
Poirier SJ
J Fam Pract; 1998 Jan; 46(1):21-7. PubMed ID: 9451365
[TBL] [Abstract][Full Text] [Related]
12. Clinical inquiries. Do ACE inhibitors prevent nephropathy in type 2 diabetes without proteinuria?
Sferra L; Kelsberg G; Dodson S; Saseen J
J Fam Pract; 2004 Jan; 53(1):68-9. PubMed ID: 14709273
[No Abstract] [Full Text] [Related]
13. Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure?
Kiberd BA; Jindal KK
Mayo Clin Proc; 1999 Jun; 74(6):559-64. PubMed ID: 10377929
[TBL] [Abstract][Full Text] [Related]
14. The road to renal failure: an overview of diabetic nephropathy.
McCrary EB
Adv Nurse Pract; 2008 Jul; 16(7):61-3. PubMed ID: 19181161
[No Abstract] [Full Text] [Related]
15. The CARI guidelines. Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes.
Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J;
Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S195-203. PubMed ID: 20591031
[No Abstract] [Full Text] [Related]
16. To prevent progression: ACE inhibitors, calcium antagonists or both?
Stefanski A; Amann K; Ritz E
Nephrol Dial Transplant; 1995; 10(2):151-3. PubMed ID: 7753444
[No Abstract] [Full Text] [Related]
17. Angiotensin-receptor blockade in renal disease: the hard issues.
Sica DA
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):469-71. PubMed ID: 15225107
[No Abstract] [Full Text] [Related]
18. Best practice for hypertensive patients with kidney disease.
de Zeeuw D
Hosp Med; 2003 Feb; 64(2):96-100. PubMed ID: 12619337
[TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy--the family physician's role.
Roett MA; Liegl S; Jabbarpour Y
Am Fam Physician; 2012 May; 85(9):883-9. PubMed ID: 22612183
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials in progression of chronic renal failure.
Striker GE; Klahr S
Adv Intern Med; 1997; 42():555-95. PubMed ID: 9048130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
